نتایج جستجو برای: transplantation hsct

تعداد نتایج: 143542  

Journal: :Open forum infectious diseases 2016
Sejal Morjaria David J Epstein Fabian A Romero Ying Taur Susan K Seo Genovefa A Papanicolaou Vaios Hatzoglou Marc Rosenblum Miguel-Angel Perales Michael Scordo Anna Kaltsas

Toxoplasma encephalitis is a well recognized complication of acquired immune deficiency syndrome, solid organ transplantation, and allogeneic hematopoietic stem cell transplantation (HSCT). However, patients with hematologic malignancies not treated with allogeneic HSCT may also develop this condition, which requires high clinical suspicion and consideration for prophylactic therapy.

2016
Rong Hu Yalan Liu Min Su Yinhong Song Debra Rood Laijun Lai

: Allogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative therapy for many malignant and nonmalignant diseases. However, chronic graft-versus-host disease (cGVHD) remains a significant cause of late morbidity and mortality after allogeneic HSCT. cGVHD often manifests as autoimmune syndrome. Thymic epithelial cells (TECs) play a critical role in supporting negative se...

Journal: :Turk pediatri arsivi 2014
Mehmet Akif Yeşilipek

Bone marrow transplantation is called hematopoetic stem cell transplantation (HSCT), since peripheral blood and umbilical cord blood can also be used as sources of stem cell currently. In children, bone marrow transplantation is used as a definite treatment method in many diseases including hemoglobinopaties, immune deficiencies, bone marrow failure and congenital metabolic diseases in addition...

2014
Suk-Young Lee Naoki Kurita Koichiro Maie Masanori Seki Yasuhisa Yokoyama Kazumi Suzukawa Yuichi Hasegawa Shigeru Chiba

Although hematopoietic stem cell transplantation (HSCT) has been considered to be the only way for potential cure of relapsed acute myeloid leukemia (AML), there has been no report on a third HSCT in patients with multiple relapsed AML. Here, we report a case of 53-year-old female who received a successful third allogeneic HSCT after relapse of AML following a second allogeneic HSCT. She was tr...

2010
Eleftheria Hatzimichael Mark Tuthill

More than 25,000 hematopoietic stem cell transplantations (HSCTs) are performed each year for the treatment of lymphoma, leukemia, immune-deficiency illnesses, congenital metabolic defects, hemoglobinopathies, and myelodysplastic and myeloproliferative syndromes. Before transplantation, patients receive intensive myeloablative chemoradiotherapy followed by stem cell "rescue." Autologous HSCT is...

Journal: :Blood 2003
Yoshinobu Kanda Shigeru Chiba Hisamaru Hirai Hisashi Sakamaki Tohru Iseki Yoshihisa Kodera Takahiro Karasuno Shinichiro Okamoto Noriyuki Hirabayashi Koji Iwato Atsuo Maruta Yoshihiro Fujimori Tatsuo Furukawa Shin Mineishi Keitaro Matsuo Nobuyuki Hamajima Masahiro Imamura

The reported outcome of hematopoietic stem cell transplantation (HSCT) from HLA-mismatched family members has been inconsistent. The object of this study was to evaluate the true impact of HLA-mismatch by using recent data from a homogenous population, excluding HSCT procedures that used graft manipulations, and by considering genotypic matching. Clinical data of 2947 patients who underwent all...

Journal: :Blood 2017
Theo de Witte David Bowen Marie Robin Luca Malcovati Dietger Niederwieser Ibrahim Yakoub-Agha Ghulam J Mufti Pierre Fenaux Guillermo Sanz Rodrigo Martino Emilio Paolo Alessandrino Francesco Onida Argiris Symeonidis Jakob Passweg Guido Kobbe Arnold Ganser Uwe Platzbecker Jürgen Finke Michel van Gelder Arjan A van de Loosdrecht Per Ljungman Reinhard Stauder Liisa Volin H Joachim Deeg Corey Cutler Wael Saber Richard Champlin Sergio Giralt Claudio Anasetti Nicolaus Kröger

An international expert panel, active within the European Society for Blood and Marrow Transplantation, European LeukemiaNet, Blood and Marrow Transplant Clinical Trial Group, and the International Myelodysplastic Syndromes Foundation developed recommendations for allogeneic hematopoietic stem cell transplantation (HSCT) in myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CM...

2017
Trude Reinfjell Marta Tremolada Lonnie K. Zeltzer

Hematopoietic stem cell transplantation (HSCT) is a standard treatment after disease relapse and failure of conventional treatments for cancer in childhood or as a first line treatment for some high-risk cancers. Since hematopoietic stem cells can be found in the marrow (previously called a bone marrow transplantation) or periphery, we refer to HSCT as inclusive of HSCT regardless of the origin...

2012
Meerim Park Jong Jin Seo

The selection of hematopoietic stem cell transplantation (HSCT) donors includes a rigorous assessment of the availability and human leukocyte antigen (HLA) match status of donors. HLA plays a critical role in HSCT, but its involvement in HSCT is constantly in flux because of changing technologies and variations in clinical transplantation results. The increased availability of HSCT through the ...

Journal: :Genetics and molecular research : GMR 2008
C B Vendrame-Goloni A B Carvalho-Salles M A Ruiz O Ricci Júnior M Varella-Garcia A C Fett-Conte

Investigation of the efficacy of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in chronic myeloid leukemia patients is essential to predict prognosis and survival. In 20 patients treated at the Bone Marrow Transplantation Unit of São José do Rio Preto (São Paulo, Brazil), we used fluorescence in situ hybridization (FISH) to investigate the frequency of cells with BCR/ABL rearra...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید